Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic treatment for lung carcinoids: from bench to bedside.
Torniai M, Scortichini L, Tronconi F, Rubini C, Morgese F, Rinaldi S, Mazzanti P, Berardi R. Torniai M, et al. Among authors: mazzanti p. Clin Transl Med. 2019 Jul 4;8(1):22. doi: 10.1186/s40169-019-0238-5. Clin Transl Med. 2019. PMID: 31273555 Free PMC article. Review.
Role of maspin in cancer.
Berardi R, Morgese F, Onofri A, Mazzanti P, Pistelli M, Ballatore Z, Savini A, De Lisa M, Caramanti M, Rinaldi S, Pagliaretta S, Santoni M, Pierantoni C, Cascinu S. Berardi R, et al. Among authors: mazzanti p. Clin Transl Med. 2013 Mar 7;2(1):8. doi: 10.1186/2001-1326-2-8. Clin Transl Med. 2013. PMID: 23497644 Free PMC article.
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.
Berardi R, Morgese F, Santinelli A, Onofri A, Biscotti T, Brunelli A, Caramanti M, Savini A, De Lisa M, Ballatore Z, Pompili C, Salati M, Mazzanti P, Torniai M, Cascinu S. Berardi R, et al. Among authors: mazzanti p. Oncotarget. 2016 Dec 13;7(50):82648-82657. doi: 10.18632/oncotarget.12244. Oncotarget. 2016. PMID: 27690341 Free PMC article.
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis.
Cantini L, Pecci F, Murrone A, Tomasetti M, Copparoni C, Fiordoliva I, Morgese F, Rinaldi S, Mazzanti P, Rubini C, Cimadamore A, Barbisan F, Giampieri R, Scarpelli M, Santarelli L, Berardi R. Cantini L, et al. Among authors: mazzanti p. Lung Cancer. 2020 Aug;146:318-326. doi: 10.1016/j.lungcan.2020.06.024. Epub 2020 Jun 21. Lung Cancer. 2020. PMID: 32622302
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach.
Berardi R, Goteri G, Brunelli A, Pagliaretta S, Paolucci V, Caramanti M, Rinaldi S, Refai M, Pompili C, Morgese F, Torniai M, Marcantognini G, Ricci G, Mazzanti P, Onofri A, Bianchi F, Sabbatini A, Cascinu S. Berardi R, et al. Among authors: mazzanti p. Expert Opin Ther Targets. 2020 Sep;24(9):937-943. doi: 10.1080/14728222.2020.1790529. Epub 2020 Jul 23. Expert Opin Ther Targets. 2020. PMID: 32662701
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.
Maccaroni E, Lenci E, Agostinelli V, Cognigni V, Giampieri R, Mazzanti P, Di Pietro Paolo M, Bianchi F, Brugiati C, Belvederesi L, Pagliaretta S, Mandolesi A, Scarpelli M, Murrone A, Morgese F, Ballatore Z, Berardi R. Maccaroni E, et al. Among authors: mazzanti p. Explor Target Antitumor Ther. 2021;2(3):240-248. doi: 10.37349/etat.2021.00044. Epub 2021 Jun 28. Explor Target Antitumor Ther. 2021. PMID: 36046437 Free PMC article.
The role of angiogenetic single-nucleotide polymorphisms in thymic malignancies and thymic benign lesions.
Berardi R, Goteri G, Pagliaretta S, Paolucci V, Morgese F, Conti A, Refai M, Pompili C, Duranti C, Marcantognini G, Savini A, Caramanti M, Rinaldi S, Torniai M, Santoni M, Zizzi A, Mazzanti P, Onofri A, Ricci G, Scarpelli M. Berardi R, et al. Among authors: mazzanti p. J Thorac Dis. 2020 Dec;12(12):7245-7256. doi: 10.21037/jtd-19-3720. J Thorac Dis. 2020. PMID: 33447413 Free PMC article.
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.
Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S. Berardi R, et al. Among authors: mazzanti p. Onco Targets Ther. 2013 May 21;6:563-76. doi: 10.2147/OTT.S28155. Print 2013. Onco Targets Ther. 2013. PMID: 23723712 Free PMC article.
293 results